MA27048A1 - Vaccin a mycoplasma bovis et methodes pour reduire la pneumonie chez des animaux - Google Patents

Vaccin a mycoplasma bovis et methodes pour reduire la pneumonie chez des animaux

Info

Publication number
MA27048A1
MA27048A1 MA27469A MA27469A MA27048A1 MA 27048 A1 MA27048 A1 MA 27048A1 MA 27469 A MA27469 A MA 27469A MA 27469 A MA27469 A MA 27469A MA 27048 A1 MA27048 A1 MA 27048A1
Authority
MA
Morocco
Prior art keywords
animals
methods
mycoplasma bovis
bovis vaccine
pneumonia
Prior art date
Application number
MA27469A
Other languages
English (en)
French (fr)
Inventor
Robin Lee Keich
Robert John Yancey
David Ross Mcgavin
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of MA27048A1 publication Critical patent/MA27048A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
MA27469A 2001-07-02 2003-12-31 Vaccin a mycoplasma bovis et methodes pour reduire la pneumonie chez des animaux MA27048A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30263801P 2001-07-02 2001-07-02

Publications (1)

Publication Number Publication Date
MA27048A1 true MA27048A1 (fr) 2004-12-20

Family

ID=23168600

Family Applications (1)

Application Number Title Priority Date Filing Date
MA27469A MA27048A1 (fr) 2001-07-02 2003-12-31 Vaccin a mycoplasma bovis et methodes pour reduire la pneumonie chez des animaux

Country Status (31)

Country Link
US (1) US20030147914A1 (enExample)
EP (1) EP1401488A1 (enExample)
JP (1) JP2004536106A (enExample)
KR (1) KR20040030783A (enExample)
CN (1) CN1522152A (enExample)
AP (1) AP2002002568A0 (enExample)
AR (1) AR036125A1 (enExample)
BG (1) BG108496A (enExample)
BR (1) BR0210798A (enExample)
CA (1) CA2452580A1 (enExample)
CZ (1) CZ20033465A3 (enExample)
EA (1) EA200301324A1 (enExample)
GT (1) GT200200139A (enExample)
HN (1) HN2002000162A (enExample)
HR (1) HRP20031078A2 (enExample)
HU (1) HUP0501188A2 (enExample)
IL (1) IL159516A0 (enExample)
IS (1) IS7078A (enExample)
MA (1) MA27048A1 (enExample)
MX (1) MXPA03011815A (enExample)
NO (1) NO20035767L (enExample)
OA (1) OA12640A (enExample)
PA (1) PA8549801A1 (enExample)
PE (1) PE20030239A1 (enExample)
PL (1) PL373891A1 (enExample)
SK (1) SK15802003A3 (enExample)
TN (1) TNSN03154A1 (enExample)
UY (1) UY27365A1 (enExample)
WO (1) WO2003004052A1 (enExample)
YU (1) YU102103A (enExample)
ZA (1) ZA200309747B (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7179473B2 (en) 1998-06-05 2007-02-20 Boehringer Ingelheim Vetmedica Gmbh Attenuated pestiviruses
US7135561B2 (en) 2001-09-06 2006-11-14 Boehringer Ingelheim Vetmedica Gmbh Infectious bovine viral diarrhea virus clone
US7279166B2 (en) * 2001-12-12 2007-10-09 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
SE0301436D0 (sv) * 2003-05-16 2003-05-16 Joakim Westberg New proteins
US7572455B2 (en) * 2004-05-19 2009-08-11 Boehringer Ingelheim Vetmedica Gmbh Vaccine comprising an attenuated pestivirus
US20090068223A1 (en) * 2005-11-15 2009-03-12 Boehringer Ingelheim Vetmedica, Inc. Combination vaccine comprising an attenuated bovine viral diarrhea virus
US20110059437A1 (en) * 2006-09-07 2011-03-10 Boehringer Ingelheim Vetmedica, Inc. Pcr-based genotyping
UA98115C2 (ru) 2006-09-11 2012-04-25 Пфайзер Продактс Инк. Композиция, которая содержит подвергнутые тепловой обработке бактерины
CL2008003202A1 (es) * 2007-10-29 2009-11-27 Boehringer Ingelheim Vetmedica Inc Composicion inmunogenica que comprende bacterias vivas de mycoplasma bovis atenuada avirulenta.
UY31930A (es) * 2008-06-25 2010-01-29 Boheringer Ingelheim Pharma Kg Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante
EP2320943B1 (en) * 2008-07-03 2016-02-17 Iowa State University Research Foundation, Inc. Cattle vaccines
SG10201506597RA (en) * 2008-10-31 2015-10-29 Boehringer Ingelheim Vetmed Use Of Various Antigens Including Antigens From Mycoplasma Bovis In Multivalent Vaccine Composition
US8846054B2 (en) * 2009-01-09 2014-09-30 Boehringer Ingelheim Vetmedica, Inc. Method of treating pregnant cows and/or heifers
UY32570A (es) * 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada
WO2010140377A1 (ja) 2009-06-04 2010-12-09 独立行政法人産業技術総合研究所 マイコプラズマ感染症用ワクチン
CN102220263B (zh) * 2011-05-06 2012-10-03 华中农业大学 一种牛支原体致弱菌株及其应用
PT2938747T (pt) 2012-12-28 2019-08-01 Boehringer Ingelheim Vetmedica Gmbh Método de preparação de uma vacina de micoplasma
CN104857509A (zh) * 2015-06-02 2015-08-26 福清市默克兽医院 牛支原体肺炎组织灭活疫苗的制备方法、配方及使用方法
DK3334454T3 (da) 2015-08-14 2022-11-14 Zoetis Services Llc Mycoplasma-Bovis-sammensætninger
AU2016380864B2 (en) 2015-12-28 2019-10-31 Boehringer Ingelheim Animal Health USA Inc. M hyo multivalent vaccine and uses thereof
CN105441368B (zh) * 2016-01-19 2019-01-01 福清市默克兽医院 一株牛支原体及其应用
CN106929452B (zh) * 2017-04-11 2020-06-12 河南省农业科学院畜牧兽医研究所 一株牛支原体及其应用
CN109022314B (zh) * 2018-08-06 2021-08-13 北京华夏兴洋生物科技有限公司 一株牛支原体及其在疫苗研制中的应用
CN110338138B (zh) * 2019-06-19 2021-04-06 山东省农业科学院奶牛研究中心 一种牛支原体感染豚鼠的动物模型构建方法及其应用
CN112301041B (zh) * 2020-10-09 2022-05-24 华中农业大学 牛支原体p21蛋白及其应用
CN113546162B (zh) * 2021-05-31 2023-07-18 江苏省农业科学院 一种支原体疫苗及其制备方法
CN113604492B (zh) * 2021-09-10 2023-07-07 苏州世诺生物技术有限公司 融合基因、融合蛋白及制备方法和牛支原体亚单位疫苗

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565205A (en) * 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
CA2390613A1 (en) * 1999-11-08 2001-05-17 Biomune Vaccines for mycoplasma bovis and methods of use
DE29921392U1 (de) * 1999-12-06 2000-03-16 Dr. Felgenträger & Co. Öko-Chem. und Pharma GmbH, 06862 Rodleben Mykoplasma-bovis-Kombinations-Vakzine für Rinder
US6548069B2 (en) * 2001-02-03 2003-04-15 Hmv Associates, Inc. Multivalent Mycoplasma bacterin

Also Published As

Publication number Publication date
EP1401488A1 (en) 2004-03-31
AR036125A1 (es) 2004-08-11
WO2003004052A1 (en) 2003-01-16
JP2004536106A (ja) 2004-12-02
ZA200309747B (en) 2005-05-27
CN1522152A (zh) 2004-08-18
YU102103A (sh) 2006-05-25
CZ20033465A3 (cs) 2004-12-15
KR20040030783A (ko) 2004-04-09
BG108496A (en) 2005-02-28
PE20030239A1 (es) 2003-03-21
GT200200139A (es) 2003-02-13
IS7078A (is) 2003-12-15
PA8549801A1 (es) 2003-09-17
IL159516A0 (en) 2004-06-01
CA2452580A1 (en) 2003-01-16
OA12640A (en) 2006-06-15
TNSN03154A1 (fr) 2005-12-23
UY27365A1 (es) 2003-04-30
EA200301324A1 (ru) 2004-12-30
HRP20031078A2 (en) 2005-08-31
NO20035767L (no) 2004-01-30
SK15802003A3 (sk) 2005-01-03
AP2002002568A0 (en) 2002-06-30
HN2002000162A (es) 2002-09-17
MXPA03011815A (es) 2004-04-02
US20030147914A1 (en) 2003-08-07
PL373891A1 (en) 2005-09-19
HUP0501188A2 (en) 2006-05-29
BR0210798A (pt) 2006-05-23

Similar Documents

Publication Publication Date Title
NO20035767L (no) Mycyplasma Bovis vaksine og fremgangsmater for redusering av pneumonia i dyr
NO2023030I1 (no) Apixaban and pharmaceutical acceptable salts thereof
FR2808366B1 (fr) Procede et systeme d'apprentissage en realite virtuelle, et application en odontologie
FI20021870L (fi) Magneettinen siirtomenetelmä ja mikropartikkelien siirtolaite
DK1296715T3 (da) Multivalent vaccinesammensætning
NO2011002I2 (no) Regadenoson og salter derav
DK1335678T3 (da) Oralt behandlingssystem
DK1228217T3 (da) Konserverede neisseria-antigener
ATE553776T1 (de) Multivalente impfstoffzusammensetzung
NO20033815L (no) Farmasöytiske salter
NO20031483D0 (no) Vaksine
DE60131258D1 (de) Trainingsgerät
NO20024172D0 (no) Vaksine
EP1423141A4 (en) VACCINE
ITBO20030639A1 (it) Dispositivo per la circolazione dell'aria in pareti
NO20030156L (no) Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav
EP1429615A4 (en) ORAL VACCINES
AT4056U3 (de) Therapie- und trainingsgerät
ATA6512000A (de) Trainingsgerät
ITRM20010541A1 (it) Metodo ed apparecchio per amministrare le proprieta' di inversione inun dispositivo di collaudo di memoria.
NO20042416L (no) Farmasoytisk sammensetning for induksjon av en immunrespons i et menneske eller dyr
ITRM20030440A1 (it) Sistema d'indicazione temporale, in particolare dell'orario.
FI20002762A0 (fi) Siirtolaite ja -menetelmä
ITBO20010404A0 (it) Dispositivo per la minzione femminile in una postura eretta
SE0001982D0 (sv) Animal model